MediWound Ltd.
NASDAQ:MDWD
Overview | Financials
Company Name | MediWound Ltd. |
Symbol | MDWD |
Currency | USD |
Price | 17.7 |
Market Cap | 190,919,280 |
Dividend Yield | 0% |
52-week-range | 10.14 - 24 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Ofer Gonen B.Sc. |
Website | https://www.mediwound.com |
An error occurred while fetching data.
About MediWound Ltd.
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD